1. MicroRNA‐181a promotes docetaxel resistance in prostate cancer cells
   Cameron M. Armstrong et al, 2017, The Prostate CrossRef
2. Effect of miR-27b on the proliferation and apoptosis of diffuse large b-cell lymphoma cells by targeting the regulation of MET/PI3K/AKT pathway
   Rui Zhang et al, 2022, Discover Oncology CrossRef
3. MAP17 contributes to non-small cell lung cancer progression via suppressing miR-27a-3p expression and p38 signaling pathway
   Qian Liang et al, 2021, Cancer Biology & Therapy CrossRef
4. Loss of KMT5C Promotes EGFR Inhibitor Resistance in NSCLC via LINC01510-Mediated Upregulation of MET
   Arpita S. Pal et al, 2022, Cancer Research CrossRef
5. miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1
   Guangwei Zhang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
6. A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay
   Ahmed S. Doghish et al, 2022, Pathology - Research and Practice CrossRef
7. The diagnostic and prognostic role of miR-27a in cancer
   Wen Bi et al, 2023, Pathology - Research and Practice CrossRef
8. Promising therapeutic role of miR-27b in tumor
   Li Ding et al, 2017, Tumor Biology CrossRef
9. Current updates on microRNAs as regulators of chemoresistance
   Metin Çalışkan et al, 2017, Biomedicine & Pharmacotherapy CrossRef